{"schema_version":"secwatch.filing_event.v1","accession":"0001077183-22-000120","form_type":"8-K/A","ticker":"NEO","cik":"0001077183","company_name":"NEOGENOMICS INC","filed_at":"2022-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.898587+00:00","generated_at":"2026-06-24T13:05:01.238057+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"NeoGenomics subsidiary settles with former CEO Clive Morris for £607,500 in termination payments","bullets":["Settlement includes £202,500 payment in lieu of notice, £303,750 retention cash bonus component, and £101,250 pro-rated MIP bonus.","Additional payment for accrued vacation and legal fees up to £2,000 plus VAT.","Dr. Morris served as CEO of Inivata Limited, a wholly owned NeoGenomics subsidiary; employment terminated June 30, 2022.","Agreement includes full release of claims, confidentiality, and non-disparagement obligations."],"urls":{"canonical":"https://secwatch.observer/filing/0001077183-22-000120","json":"https://secwatch.observer/filing/0001077183-22-000120.json","markdown":"https://secwatch.observer/filing/0001077183-22-000120.md","text":"https://secwatch.observer/filing/0001077183-22-000120.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000120/0001077183-22-000120-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000120/neo-20220505.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T13:05:01.238057+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}